Various functional impairments in eye movements have been observed in Alzheimer's disease (AD) and other neurodegenerative disorders. Detecting abnormal eye movements may help identify individuals at risk of memory diseases even when evident clinical symptoms are absent.
Objective
To investigate the earliest possible stage at which the risk of memory impairment can be detected using computer-based eye-tracking (ET) analysis of King-Devick (KD) test performance.
Methods
We recruited a total of 34 healthy controls and 33 participants with a Clinical Dementia Rating-Sum of Boxes (CDR-SOB) score of 0.5 or higher. They all underwent a neurological examination, the Consortium to Establish a Registry for Alzheimer's Disease neuropsychological test battery (CERAD-NB), and a CDR interview. The KD reading test was performed using computer-based ET. We analyzed fixation durations, saccade durations, and saccade amplitudes. For this study, test results were analyzed in relation to CDR-SOB.
Results
The mean duration of saccades was significantly shorter in the CDR-SOB 0.5 group compared to healthy controls (p = 0.001), and this difference remained significant across groups with CDR-SOB >0.5. The mean amplitude of saccades was significantly lower in individuals with CDR-SOB scores ranging from 1 to 4, as well as those with scores exceeding 4.5, in comparison to healthy controls (p = 0.007).
Conclusions
These findings suggest that ET analysis of the KD test may help detect individuals with very early cognitive problems. Therefore, this method shows promise as a supportive or potentially indicative biomarker for future studies aimed at developing user-friendly tools to identify individuals at risk for AD or other memory diseases.
JackCRJrAndrewsJSBeachTG, et al.Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup. Alzheimers Dement2024; 20: 5143–5169.
OpwonyaJWangCJangKM, et al.Inhibitory control of saccadic eye movements and cognitive impairment in mild cognitive impairment. Front Aging Neurosci2022; 14: 871432.
4.
KusneYWolfABTownleyK, et al.Visual system manifestations of Alzheimer’s disease. Acta Ophthalmol2017; 95: e668–e676.
5.
LueckKLMendezMFPerrymanKM. Eye movement abnormalities during reading in patients with Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol2000; 13: 77–82.
6.
FernandezGMandolesiPRotsteinNP, et al.Eye movement alterations during reading in patients with early Alzheimer disease. Invest Ophthalmol Vis Sci2013; 54: 8345–8352.
7.
del Carmen Pérez-SánchezMGonzález-NostiMCuetosF, et al.Reading fluency in Spanish patients with Alzheimer’s disease. Curr Alzheimer Res2021; 18: 243–255.
8.
HoldenJGCosnardALaurensB, et al.Prodromal Alzheimer’s disease demonstrates increased errors at a simple and automated anti-saccade task. J Alzheimers Dis2018; 65: 1209–1223.
9.
HannonenSAndbergSKärkkäinenV, et al.Shortening of saccades as a possible easy-to-use biomarker to detect risk of Alzheimer’s disease. J Alzheimers Dis2022; 88: 609–618.
10.
OpwonyaJDoanDNTKimSG, et al.Saccadic eye movement in mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. Neuropsychol Rev2022; 32: 193–227.
11.
PereiraMLGFCamargoMVZABellanAFR, et al.Visual search efficiency in mild cognitive impairment and Alzheimer’s disease: an eye movement study. J Alzheimers Dis2020; 75: 261–275.
12.
BaderIGrootCTanHS, et al.Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic. Alzheimers Res Ther2024; 16: 190.
13.
GalettaKMLiuMLeongDF, et al.The King-Devick test of rapid number naming for concussion detection: meta-analysis and systematic review of the literature. Concussion2015; 1: CNC8.
14.
LinTPAdlerCHHentzJG, et al.Slowing of number naming speed by King-Devick Test in Parkinson’s disease. Parkinsonism Relat Disord2014; 20: 226–229.
15.
GalettaKMChapmanKREssisMD, et al.Screening utility of the King-Devick test in mild cognitive impairment and ALZHEIMER disease dementia. Alzheimer Dis Assoc Disord2017; 31: 152–158.
16.
PeltschAHemrajAGarciaA, et al.Saccade deficits in amnestic mild cognitive impairment resemble mild Alzheimer’s disease. Eur J Neurosci2014; 39: 2000–2013.
17.
PoldenMCrawfordTJ. Active visual inhibition is preserved in the presence of a distracter: a cross-cultural, ageing and dementia study. Cortex2021; 142: 169–185.
18.
ReadmanMRPoldenMGibbsMC, et al.The potential of naturalistic eye movement tasks in the diagnosis of Alzheimer’s disease: a review. Brain Sci2021; 11: 1503.
SekarAPanouillèresMTNKaskiD. Detecting abnormal eye movements in patients with neurodegenerative diseases - current insights. Eye Brain2024; 16: 3–16.
21.
TeraoYTokushigeSIInomata-TeradaS, et al.How do patients with Parkinson’s disease and cerebellar ataxia read aloud? - Eye–voice coordination in text reading. Front Neurosci2023; 17: 1202404.
22.
ReimanEMMcKhannGMAlbertMS, et al.Clinical impact of updated diagnostic and research criteria for Alzheimer’s disease. J Clin Psychiatry2011; 72: e37.
23.
WelshKAButtersNMohsRC, et al.The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology1994; 44: 609–614.
24.
MorrisJC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology1993; 43: 2412–2414.
25.
MohebpourIMalek-AhmadiMVirdenT, et al.Neuropathologic validation of the Alzheimer’s Questionnaire. Aging Clin Exp Res2022; 34: 2905–2909.
26.
O’BryantSEWaringSCCullumCM, et al.Staging dementia using clinical dementia rating scale sum of boxes scores: a Texas Alzheimer’s research consortium study. Arch Neurol2008; 65: 1091–1095.
27.
YangYWHsuKCWeiCY, et al.Operational determination of subjective cognitive decline, mild cognitive impairment, and dementia using sum of boxes of the clinical dementia rating scale. Front Aging Neurosci2021; 13: 705782.
28.
FillenbaumGGMohsR. CERAD (Consortium to Establish a Registry for Alzheimer’s Disease) neuropsychology assessment battery: 35 years and counting. J Alzheimers Dis2023; 93: 1–27.
29.
PaajanenTHänninenTTunnardC, et al.CERAD Neuropsychological compound scores are accurate in detecting prodromal Alzheimer’s disease: a prospective AddNeuroMed study. J Alzheimers Dis2014; 39: 679–690.
30.
GalettaKMBrandesLEMakiK, et al.The King-Devick test and sports-related concussion: study of a rapid visual screening tool in a collegiate cohort. J Neurol Sci2011; 309: 34–39.
LagunDManzanaresCZolaSM, et al.Detecting cognitive impairment by eye movement analysis using automatic classification algorithms. J Neurosci Methods2011; 201: 196–203.
34.
FernándezGSchumacherMCastroL, et al.Patients with mild Alzheimer’s disease produced shorter outgoing saccades when reading sentences. Psychiatry Res2015; 229: 470–478.
35.
SuzukiAShinozakiJYazawaS, et al.Establishing a new screening system for mild cognitive impairment and Alzheimer’s disease with mental rotation tasks that evaluate visuospatial function. J Alzheimers Dis2018; 61: 1653–1665.
36.
HaesnerMChandraJSteinertA, et al.An eye movement analysis of web usability: differences between older adults with and without mild cognitive impairment. Assist Technol2018; 30: 66–73.
37.
AkkoyunMKoçoğluKEraslan BozH, et al.Visual search for real-world scenes in patients with Alzheimer’s disease and amnestic mild cognitive impairment. Brain Behav2024; 14: e3567.
38.
Eraslan BozHKoçoğluKAkkoyunM, et al.Visual search in Alzheimer’s disease and amnestic mild cognitive impairment: an eye-tracking study. Alzheimers Dement2024; 20: 759–768.
39.
ParraMAGranadaJFernándezG. Memory-driven eye movements prospectively predict dementia in people at risk of Alzheimer’s disease. Alzheimers Dement (Amst)2022; 14: e12386.
40.
DongYLiJZhouM, et al.Cortical regulation of two-stage rapid eye movement sleep. Nat Neurosci2022; 25: 1675–1682.
41.
LehtolaJMKärkkäinenVAndbergS, et al.Computer-based eye-tracking analysis of King-Devick test differentiates persons with idiopathic normal pressure hydrocephalus from cognitively unimpaired. Alzheimer Dis Assoc Disord2022; 36: 340–346.
42.
LiDButalaAAMoro-VelazquezL, et al.Automating the analysis of eye movement for different neurodegenerative disorders. Comput Biol Med2024; 170: 107951.
